What happens after the EUDAMED deadline passes?

When the EUDAMED deadline passes on May 28, 2026, medical device manufacturers face immediate regulatory compliance obligations and potential market access restrictions. Companies that miss the deadline cannot place new devices on the EU market until they complete mandatory actor and device registration. However, existing devices already on the market can continue to be sold during a limited transition period while manufacturers work to achieve compliance.

What Actually Happens When the EUDAMED Deadline Passes?

After May 28, 2026, the four validated EUDAMED modules become mandatory for all medical device manufacturers, authorized representatives, and distributors operating in the EU market. Immediate enforcement begins for new device placements, meaning any medical device or IVD first placed on the EU market after this date must have completed EUDAMED registration before distribution can occur.

The post-deadline regulatory environment creates several immediate changes:

• Mandatory registration requirements – Voluntary compliance transforms into a legal obligation with active enforcement
• Single Registration Number (SRN) requirement – Manufacturers must obtain their SRN through the Actor module before any device registration
• Enhanced authorized representative responsibilities – European Authorized Representatives assume verification responsibilities for non-EU manufacturers
• Real-time market surveillance – Competent authorities gain enhanced oversight capabilities through the fully functional EUDAMED database
• Certificate linkage obligations – The Notified Bodies Certificates module becomes mandatory, requiring proper linkage between device registrations and CE marking certificates

These changes fundamentally shift the regulatory landscape from voluntary participation to mandatory compliance, creating immediate visibility into manufacturer compliance status and enabling authorities to actively monitor and enforce registration requirements across all EU market participants.

Can You Still Sell Medical Devices in the EU After Missing the EUDAMED Deadline?

Existing medical devices already placed on the EU market before May 28, 2026, can continue to be sold even if EUDAMED registration is incomplete. However, no new devices can enter the market without proper registration, creating a clear distinction between existing inventory and new product launches.

The enforcement approach creates specific limitations for non-compliant manufacturers:

• Continued sales of existing devices – Products already on the market can remain in distribution channels during the transition period
• Prohibition on new market entries – Any device modifications, new variants, or updated configurations require fresh EUDAMED registration
• Legacy device requirements – Devices remaining CE marked under MDD, AIMDD, or IVDD also require registration if they continue to be placed on the market
• Variable grace periods – Enforcement timelines vary by member state and competent authority priorities
• Actor registration bottlenecks – The prerequisite approval process involves multiple parties and can extend compliance timelines beyond manufacturers’ control

This enforcement structure allows manufacturers to maintain revenue streams from established products while creating urgent pressure to complete registration requirements for any future market activities, making early submission critical for preserving long-term market access rights.

How Do You Register in EUDAMED After the Deadline Has Passed?

Post-deadline EUDAMED registration follows the same technical process but operates under heightened scrutiny and potential enforcement pressure. Actor registration must be completed first, requiring coordination between manufacturers, authorized representatives, and competent authorities for approval and SRN assignment.

The registration process involves several critical steps that must be completed sequentially:

• Actor registration submission – Complete documentation must be submitted through European Authorized Representatives who verify before forwarding to competent authorities
• Data quality verification – Minor mistakes such as missing attachments or inconsistencies can result in rejections that restart the review timeline
• Device registration preparation – UDI Database registration becomes available only after actor registration approval
• Comprehensive device data compilation – Basic UDI-DI, risk classification, storage conditions, critical warnings, and proper EMDN coding must be complete and accurate
• Technical validation testing – Submission methods including manual entry, XML uploads, or machine-to-machine integration require early testing to identify potential issues

Technical validation represents the most common source of delays, particularly around controlled vocabularies, reference codes, and formatting requirements that can prevent successful submission and require complete remediation before resubmission attempts.

What Are the Long-Term Consequences of Late EUDAMED Compliance?

Late EUDAMED compliance creates cascading effects across regulatory relationships, market surveillance obligations, and competitive positioning within EU markets. Delayed registration establishes a compliance history that may influence future interactions with competent authorities and affect the scrutiny applied to subsequent regulatory submissions.

The long-term implications of delayed compliance extend across multiple operational areas:

• Intensified market surveillance – Authorities prioritize oversight of companies with compliance delays, extending to post-market surveillance and quality system inspections
• Commercial disadvantage – Healthcare providers and procurement organizations verify supplier compliance status, making registration a competitive differentiator in tenders
• Resource allocation strain – Organizations must manage ongoing MDR/IVDR obligations while dedicating capacity to database registration and validation activities
• Future module preparation challenges – Late compliance with initial requirements compounds preparation for subsequent phases like the Vigilance module anticipated in Q2 2027
• Regulatory relationship impact – Compliance patterns influence future authority interactions and may affect the scrutiny applied to other regulatory submissions

These consequences create a compounding effect where initial delays generate ongoing operational challenges and competitive disadvantages that extend well beyond the immediate registration requirements, making prompt compliance resolution essential for maintaining market position and regulatory standing.

How MedEnvoy Global Helps With EUDAMED Compliance After the Deadline

MedEnvoy Global provides comprehensive solutions for manufacturers facing post-deadline EUDAMED compliance challenges, streamlining the registration process and minimizing market access disruptions. Our specialized approach addresses the complex technical and regulatory requirements while ensuring accurate and timely submissions to restore compliance status.

• Expert European Authorized Representative services – Complete actor registration management with direct competent authority coordination
• Technical validation and data preparation – Comprehensive device data compilation, UDI database management, and submission testing
• Regulatory strategy development – Prioritized compliance roadmaps that minimize market disruption while meeting mandatory requirements
• End-to-end submission management – From initial actor registration through device database completion with ongoing support
• Quality assurance protocols – Multi-stage validation processes that prevent common submission errors and delays

Don’t let EUDAMED compliance challenges compromise your EU market access. Contact MedEnvoy Global today to develop a strategic approach that restores your regulatory standing and positions your organization for long-term success in the European market.

Related Articles

• Is the Netherlands a Good Entry Point for Europe?
• What happens if I miss the EUDAMED deadline?
• Is the European Medical Device Market Worth It?
• What Quality Certifications Do I Need for Europe?
• How Much Should I Budget for European Market Entry?